top of page
.png)
India Alternatives’ portfolio company Brinton Pharmaceuticals gets nod for selling covid-19 tablet
Brinton Pharmaceuticals has got the approval of the Drugs Controller General of India (DCGI) for marketing favipiravir under the brand name Faviton for the management of mild to moderate covid-19 patients.
For more details, please click on the following link:
bottom of page